Kymera presents preclinical IBD data for oral IRF5 degrader KT-579

Go back to Kymera presents preclinical IBD data for oral IRF5 degrader KT-579
(NASDAQ: KYMR) Delayed: 96.89 -2.56 (2.57%)
Previous Close $99.45    52 Week High
Open $97.77    52 Week Low
Day High $100.69    P/E N/A 
Day Low $94.62    EPS
Volume 847,679